Home / Conditions / Allergy
Allergy: when insurers say no, reviewers often say yes
In 58 published external-review decisions involving allergy, independent physician reviewers overturned the insurer’s denial 10.3% of the time.
Published decisions
58
2001–2026
Overturned
10.3%
6 denials reversed
Most-fought treatments for allergy
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Allergy Testing | 23 | 0% |
| Lab Work | 13 | 0% |
| Allergy Rx | 9 | 66.7% |
| Ongoing OON Tx | 8 | 0% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 42 | 0% |
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 16 | 37.5% |
Typical time to a decision
21 days
Most land between 13 and 24 days
Handled as urgent
20.7%
Expedited when a delay would cause harm
Recent direction
Rising
2.8% → 8.3% overturned, last three years
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for prednisolone sodium phosphate oral dissolving tablets (Orapred-ODT). It is critical for this for this patient’s family and caregivers to have immediate access to emergency medications, such as epinephrine autoinjectors in case of allergic reactions that occur outside the presence of medical supervision. In addition, adjunctive medications such as systemic steroids and antihistamines, can also be helpful to alleviate the patient’s symptoms. Although systemic steroids should not be used for initial therapy, there is support for their use as an adjunctive therapy per the American Academy of Allergy, Asthma and Immunology (AAAAI) and American College of Allergy, Asthma and Immunology (ACAAI) practice parameters.
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for prednisolone sodium phosphate oral dissolving tablets (Orapred-ODT). It is critical for this for this patient’s family and caregivers to have immediate access to emergency medications, such as epinephrine autoinjectors in case of allergic reactions that occur outside the presence of medical supervision. In addition, adjunctive medications such as systemic steroids and antihistamines, can also be helpful to alleviate the patient’s symptoms. Although systemic steroids should not be used for initial therapy, there is support for their use as an adjunctive therapy per the American Academy of Allergy, Asthma and Immunology (AAAAI) and American College of Allergy, Asthma and Immunology (ACAAI) practice parameters.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: Allergen-specific IgG4 testing has not been demonstrated in randomized controlled clinical trials to be effective for routine clinical care and is not recommended for the evaluation of IgE-mediated food allergies per expert panel guidelines due to lack of evidence. Also noted in the 2014 Joint Task Force Updated Food Allergy Practice Parameters, “allergen-specific IgG measurement…should not be used for the evaluation of food allergy”. Similarly, allergen-specific IgG testing is not included in recommendations for diagnosis of non-IgE mediated immunologic adverse reactions to foods.
Nature of Statutory Criteria/Case Summary: Allergen-specific IgG4 testing has not been demonstrated in randomized controlled clinical trials to be effective for routine clinical care and is not recommended for the evaluation of IgE-mediated food allergies per expert panel guidelines due to lack of evidence. Also noted in the 2014 Joint Task Force Updated Food Allergy Practice Parameters, “allergen-specific IgG measurement…should not be used for the evaluation of food allergy”. Similarly, allergen-specific IgG testing is not included in recommendations for diagnosis of non-IgE mediated immunologic adverse reactions to foods.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for allergy was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.